Coherus BioSciences Inc - ESG Rating & Company Profile powered by AI
This report of Coherus BioSciences Inc is prepared by All Street Sevva using advanced machine learning. This Disclosure rating includes 17 United Nations Sustainable Development Goals including: 'No Poverty', 'Climate Action' and 'Life on Land'. If you work at Coherus BioSciences Inc and you wish to licence your ESG aseessment, please contact us.
Coherus BioSciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 1.6, social score of 4.8 and governance score of 6.7.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1252 | Wntresearch AB | 4.5 | High |
| 1252 | Verano Holdings Corp | 4.5 | High |
| 1284 | Coherus BioSciences Inc | 4.4 | High |
| 1284 | Adinath Biolabs Ltd | 4.4 | High |
| 1284 | Aligos Therapeutics Inc | 4.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Coherus BioSciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Coherus BioSciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Coherus BioSciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Coherus BioSciences Inc offer flexible work?
Sign up for free to unlockDoes Coherus BioSciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Coherus BioSciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Coherus BioSciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose water use targets?
Sign up for free to unlockDoes Coherus BioSciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Coherus BioSciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Coherus BioSciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Coherus BioSciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Coherus BioSciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Coherus BioSciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Coherus BioSciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose its waste policy?
Sign up for free to unlockDoes Coherus BioSciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose energy use targets?
Sign up for free to unlockDoes Coherus BioSciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Coherus BioSciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Coherus BioSciences Inc
These potential risks are based on the size, segment and geographies of the company.
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.